you are here:

Dr Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE089A01023 | SECTOR: Pharmaceuticals

BSE Live

Nov 27, 16:00
4829.60 -69.20 (-1.41%)
Volume
AVERAGE VOLUME
5-Day
60,608
10-Day
47,930
30-Day
58,967
34,183
  • Prev. Close

    4898.80

  • Open Price

    4898.80

  • Bid Price (Qty.)

    4829.60 (651)

  • Offer Price (Qty.)

    4829.60 (5)

NSE Live

Nov 27, 15:59
4828.95 -72.40 (-1.48%)
Volume
AVERAGE VOLUME
5-Day
2,080,998
10-Day
1,584,570
30-Day
1,757,744
2,003,738
  • Prev. Close

    4901.35

  • Open Price

    4901.00

  • Bid Price (Qty.)

    4828.95 (5190)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2019 2018 2017 2016 2015
Half Yearly Results of Dr Reddys Laboratories (in Rs. Cr.) Sep '20 Mar '20 Sep '19 Mar '19 Sep '18  
Net Sales/Income from operations 6,570.40 5,881.90 5,954.70 5,312.10 5,154.60  
Other Operating Income 19.80 13.80 -- 64.80 94.00  
Total Income From Operations 6,590.20 5,895.70 5,954.70 5,376.90 5,248.60  
EXPENDITURE  
Consumption of Raw Materials 1,604.70 1,327.30 1,229.20 1,069.40 1,033.80  
Purchase of Traded Goods 604.60 572.20 545.00 494.00 374.60  
Increase/Decrease in Stocks -328.70 -32.90 -67.00 81.20 -15.20  
Power & Fuel -- -- -- -- --  
Employees Cost 1,153.00 1,027.80 1,002.40 961.90 970.00  
Depreciation 411.90 388.10 401.10 397.70 382.90  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses 1,799.30 -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses -- 1,724.80 1,653.60 1,646.90 1,719.20  
P/L Before Other 1,345.40 888.40 1,190.40 725.80 783.30  
Other Income 659.30 196.70 548.10 165.50 82.90  
P/L Before Int. 2,004.70 1,085.10 1,738.50 891.30 866.20  
Interest 23.30 23.50 24.30 24.50 32.30  
P/L Before Exceptional Items & Tax 1,981.40 1,061.60 1,714.20 866.80 833.90  
Exceptional Items -- -- -- -- --  
P/L Before Tax 1,981.40 1,061.60 1,714.20 866.80 833.90  
Tax 550.20 37.10 -199.00 264.60 158.80  
P/L After Tax from Ordinary Activities 1,431.20 1,024.50 1,913.20 602.20 675.10  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 1,431.20 1,024.50 1,913.20 602.20 675.10  
Equity Share Capital 83.10 83.10 83.10 83.00 83.00  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 86.31 61.64 115.42 -- 40.67  
Diluted EPS 86.08 -- 115.21 -- 40.62  
EPS After Extra Ordinary  
Basic EPS. 86.31 61.64 115.42 -- 40.67  
Diluted EPS. 86.08 -- 115.21 -- 40.62  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores). -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group). -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company). -- -- -- -- --  
Source : Dion Global Solutions Limited